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ABSTRACT. Objective: The purpose of this study was to examine
the effectiveness of an alcohol brief intervention (ABI) on alcohol
consumption in hazardous or harmful drinkers compared with screen-
ing alone within a general hospital setting. Method: Following screen-
ing, 124 hazardous or harmful drinkers (103 men, ages 18–80 years,
score of 3–12 on the Fast Alcohol Screening Test [FAST]) admitted to
medical and orthopedic wards during the 13-month recruitment period
were randomized to receive an ABI or control. The intervention group
received anABI where they were supported to set their own personalized
alcohol reduction goals, and both groups received a health information
leaﬂet. Retrospective alcohol consumption for 7 days was reported for
the week, before hospital admission and 6 months after it. Results: De-
mographics and clinical characteristics at baseline showed no statistical
differences between the two groups on all variables except FAST score,
which was higher in the intervention group (p ≤ .05). A reduction of 85
grams of alcohol per week (95% CI [162.46, 7.54]) was observed be-
tween groups in favor of the intervention group based on changes from
baseline. However, there was no signiﬁcant difference between groups
for absolute grams of alcohol per week at 6 months. A signiﬁcant mean
difference in favor of the intervention group (U = 1,537, p = .043) was
observed for weekly heavy drinking episodes. Conclusions: Our results
suggest screening with delivery of ABI for harmful/hazardous drinkers
in a general hospital is beneﬁcial in reducing alcohol consumption com-
pared with screening alone. (J. Stud. Alcohol Drugs, 76, 838–844, 2015)
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AROUND 2 BILLION PEOPLE WORLDWIDEconsume alcoholic beverages, and more than 76
million people have alcohol use disorders (Editorial, 2009).
Alcohol is a major contributory factor to ill health, chronic
disease, and injury globally. In 2012, it was estimated that
3.3 million deaths, or 5.9% of all deaths, were attributable
to alcohol consumption (World Health Organization, 2014).
Patterns and volumes of alcohol consumption contribute
to many disease categories such as cancer, cardiovascular
disease, liver cirrhosis, and injuries to others through
the dangerous actions of those intoxicated, such as drink
driving and violence (Rehm et al., 2009). The consequences
of harmful alcohol use are of major concern to healthcare
services. Health professionals working in general hospital
environments have regular contact with individuals who
misuse alcohol. Historically, interventions were offered
only when individuals were diagnosed as alcohol dependent,
although evidence has suggested possible beneﬁts from
intervening earlier using screening and brief interventions
(Nilsen et al., 2008; Wilk et al., 1997).
Alcohol brief interventions (ABIs) consist of a moti-
vational counseling approach involving a time-limited,
one-to-one intervention focusing on changing behavior
and enhancing an individual’s ability to reduce alcohol
consumption. ABIs are targeted at non–treatment-seeking,
non–alcohol-dependent, hazardous, and harmful drinkers and
are intended as an early intervention (Nilsen, 2010). These
interventions go beyond advice about reducing alcohol con-
sumption and focus more personally on the individual (Mc-
Queen et al., 2006). Previous work has evaluated a range of
intercessions categorized as brief interventions, with six key
elements widely summarized under the acronym FRAMES
(originally described by Bien et al., 1993): feedback, re-
sponsibility, advice, menu of strategies, empathy, and self-
efﬁcacy. Historically, headlines in the literature highlight a
conﬂicting and confusing picture of brief interventions, for
example, “Brief interventions good in theory, but weak in
practice” (Roche & Freeman, 2004), and “Brief interven-
tions have expanded in range, but how they work is still
a mystery” (Heather, 2003). There is established evidence
relating to ABIs delivered in primary care, with a Cochrane
systematic review showing that ABIs reduce the quantity of
alcohol consumed by an average of 38 g per week (Kaner
et al., 2007). In contrast, evidence for the delivery of ABIs
in a general hospital setting has remained inconclusive and
an area requiring further study (Emmen et al., 2004; Saitz,
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2007). The ﬁrst study into ABI in general hospitals observed
improvements in self-reported problems related to alcohol
but not alcohol consumption (Chick et al., 1985). A system-
atic review of ABI in general hospitals included 14 studies
with 4,041 participants and identiﬁed the need for further
research on the optimal content and treatment exposure for
ABI (McQueen et al., 2011).
This study examines the effectiveness of screening plus
an ABI on alcohol consumption in hazardous or harmful
drinkers compared with screening alone within a general
hospital setting.
Method
Study design and baseline data collection
We used a randomized controlled trial design conducted
and reported according to the Consolidated Standards of Re-
porting Trials (CONSORT) statement (Schulz et al., 2010).
Ethical approval was granted by the South Glasgow Research
Ethics Committee (ref.: 08/S0710/49). The required sample
size was calculated with 95% conﬁdence and 80% power to
detect a difference between the groups of 75 g of alcohol
per week (nine standard drinks, U.K. units), representing a
clinically signiﬁcant change, with a standard deviation of
200 g. With an estimated 30% attrition rate, 294 patients
were required.
Potentially eligible participants comprised inpatients of
any gender, between 18 and 80 years of age. Participants
comprised those admitted to the medical and orthopedic
wards of a General Hospital in Glasgow, U.K., during the
13-month recruitment period and scoring between 3 and 12
on the 16-point Fast Alcohol Screening Test (FAST) (those
scoring >12 were deemed more likely to be alcohol depen-
dent) (Hodgson et al., 2002). Those participants identiﬁed as
cognitively impaired (i.e., scoring less than 23 on the Mini-
Mental State Examination; Folstein et al., 1975), terminally
ill, or medically unstable were excluded. Patients already
known to the Community Alcohol Team or identiﬁed as
alcohol dependent were also excluded, as were non–English
speakers.
Potentially eligible participants were screened using the
FAST by a trained clinical researcher, in collaboration with
ward-based nursing and medical staff. The FAST tool con-
sists of four questions designed to measure alcohol misuse
and its consequences. Each question is scored between 0
and 4 (maximum score = 16); a score of 3 or more is used
to identify alcohol problems. The FAST is quick to admin-
ister and score and was devised for use in medical settings
where time is a factor (Coulton et al., 2009; Hodgson et
al., 2002). Screening took place within the orthopedic and
medical wards, 5 days a week, as soon as possible follow-
ing hospital admission. Eligible patients were given both
verbal and written information about the trial, and those
willing to participate signed a consent form at face-to-face
interviews.
Following consent, baseline data were collected using
the FAST tool and the retrospective drinking diary was
completed using the 7-day Timeline Followback method
(Del Boca & Darkes, 2003; Sobell & Sobell, 2003). Each
participant was then randomized by an independent thera-
pist not involved in the trial into either the control or ABI
(intervention) group via the use of numbered, opaque, sealed
envelopes. In this way, the clinical researcher could not
inﬂuence which participants were allocated to each group,
thereby limiting bias through inadequate allocation conceal-
ment (Higgins & Green, 2011).
A different researcher (blind to group allocation) collect-
ed data at 6-month follow-up using FAST and the retrospec-
tive drinking diary via telephone interviews. Heavy drinking
episodes were calculated by counting the number of days
per week in which participants consumed 64 g of alcohol or
more (eight U.K. units) for men or 48 g of alcohol (six U.K.
units) for women.
Intervention
The intervention group received usual hospital care plus
screening via the FAST, a health information leaﬂet, and the
ABI. The clinical researcher—a physiotherapist who had
received an intensive 2-day training program in ABI—deliv-
ered the intervention and received supervision from the ﬁrst
author (J.M.M.), an occupational therapist with 15 years of
clinical and 12 years of supervisory experience. Supervision
took place on a weekly basis for the ﬁrst 2 months, reduc-
ing to monthly once the clinical researcher felt conﬁdent.
The ABI was delivered while participants were still in the
hospital; a one-to-one intervention lasting a maximum of
20 minutes. The focus of the ABI was on changing behavior
using the FRAMES approach originally described by Bien
et al. (1993). During the ABI session, participants were sup-
ported using a motivational counseling approach to set their
own personalized alcohol-reduction goals. The ABI focused
on the following—feedback: using the baseline assessment
to support participants to recognize the effect of their drink-
ing, leading to increased responsibility; responsibility: par-
ticipants are encouraged to think about the role alcohol plays
and factors in their lives that may inﬂuence their alcohol
consumption; advice: speciﬁc personalized advice is co-
created by the participant and clinical researcher by asking
what might make a difference to reduce alcohol consump-
tion; menu of strategies: participants are encouraged to set
their own goals, to suit their current situation and lifestyle;
empathy: the intervention is delivered in a nonjudgmental,
supportive manner aiming to establish rapport with the
participant; and self-efﬁcacy: conﬁdence is built through a
personalized plan, considering what success would look like
for this individual.
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FIGURE 1. Consolidated Standards of Reporting Trials (CONSORT) ﬂow diagram reporting recruitment and retention through trial. FAST = Fast Alcohol
Screening Test.
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Because of the potential for hospital stays to be short,
ABI was delivered as soon as possible following screen-
ing and randomization. Participants in the intervention
group also received a personalized follow-up letter or text
message from the clinical researcher within 1 month of
discharge from the hospital. This discharge contact sought
to reinforce the intervention. The precise method of deliv-
ery (i.e., letter or text) was based on the participant’s stated
preference. The control group received usual hospital care
plus the same screening (FAST) and general health infor-
mation leaﬂet.
Outcomes
A retrospective drinking diary was used at baseline and
6-month follow-up. Follow-up assessments were completed
by telephone by a researcher who was blind to group alloca-
tion. The primary outcome measure was changes in grams
of alcohol per week from baseline to 6-month follow up.
Secondary outcomes were absolute weekly alcohol consump-
tion in grams per week at 6 months follow-up and changes
in the number of heavy drinking episodes per week.
Statistical analysis
The data collected were analyzed using SPSS (SPSS Inc.,
Chicago, IL). Inferential statistical analyses were used to
evaluate the effectiveness of the trial interventions. Primary
analyses were by intention to treat. For continuous variables
with a nonnormal distribution (grams per week, heavy drink-
ing episodes per week), the Mann–Whitney U test was used
to test for statistical signiﬁcance in consumption between
groups.
Results
Screening and recruitment
Screening took place over a 13-month period in medical
wards and over a 10-month period in orthopedic wards, us-
ing the FAST score and inclusion criteria to assess eligibil-
ity for entry into the trial (Figure 1). Of the 3,761 patient
admissions, 2,398 patients were screened; 330 (14%) had a
FAST score of 3–12 points (indicative of hazardous/harm-
ful drinking) and were therefore eligible for inclusion in the
trial. Of these 330 patients, 124 (38%) agreed to participate,
provided consent, and were randomized to one or another
arm of the trial: 63 to the intervention group and 61 to the
control group.
Although the ﬁnal recruitment numbers are lower from
the orthopedic wards (n = 49) than from the medical wards
(n = 75) (partly because of the shorter period of recruitment
and the lower number of patients admitted to the orthopedic
wards), proportionately more hazardous/harmful drinkers
(with a FAST score of 3–12 points) were identiﬁed in the
orthopedic wards (22%, n = 136) compared with the medical
wards (11%, n = 194).
Baseline characteristics
Baseline characteristics of the participants are shown, by
intervention status, in Table 1. The intervention and control
groups were analogous for most baseline characteristics
(e.g., age, gender, employment status, and units/grams of
alcohol per week). The only difference was seen in relation
to the mean FAST score. This was higher in the intervention
group, which had a mean score of 6 (range: 3–12) compared
with the control group, which had a mean score of 5 (range:
3–12). Based on the Mann–Whitney U test, this represented
a statistically signiﬁcant difference, with a mean difference
of 1.2 (U = 1,343, p = .003).
Follow-up assessment
Eighty-seven participants were successfully followed up
at 6 months, a 70% follow-up rate. More participants were
lost to follow-up in the intervention group (n = 21) than in
the control group (n = 16), but this difference was not sta-
tistically signiﬁcant, &2(1) = 0.78, p = .436. Further analysis
examined whether characteristics of participants lost to
follow-up were different from those who completed the trial.
Those participants lost to follow-up tended to be younger
than those who continued in the trial, with mean ages of
40 and 47 years, respectively (p = .03), based on results of
independent sample t tests.
Effects of the intervention
Primary outcome measure. The primary outcome mea-
sure was changes from baseline in grams of alcohol per
week. Participants in the intervention group reduced their
alcohol consumption more than those in the control group.
The average decrease for the intervention group was 97
g per week (n = 63) compared with 12 g per week for
the control group (n = 61). The difference between these
means was 85 g reduction per week (95% CI [162.46,
7.54]) in favor of the intervention group (p = .03). This
represents both a statistically signiﬁcant and clinically im-
portant difference (Table 2).
Secondary outcome measures.Absolute alcohol consump-
tion in grams per week at 6 months revealed that those par-
ticipants in the intervention group were drinking on average
169 g of alcohol per week (21.1 U.K. units) compared with
219 g of alcohol per week (27.4 U.K. units) in the control
group. Although those participants in the intervention group
were drinking less than those in the control group by more
than 6 U.K. units (50 g) per week, this difference was not
statistically signiﬁcant (U = 1,727, p = .33) (Table 2).
842 JOURNAL OF STUDIES ONALCOHOLAND DRUGS / NOVEMBER 2015
TABLE 1. Demographic and clinical characteristics of participants at baseline (n = 124)
Total Intervention Control
sample group group
Variable (n = 124) (n = 63) (n = 61) p
Age, in years .546a
M (SD) 45 (17) 46 (16) 43 (17)
Range 18–80 18–80 18–79
FAST .003*,b
M (SD) 5 (2.4) 6 (2.4) 5 (2.3)
Range 3–12 3–12 3–12
Units per week .229b
M (SD) 32 (30) 35 (31) 28 (30)
Range 0–194c 0–162c 0–194c
Grams per week .241b
M (SD) 246 (243) 270 (177) 220 (154)
Range 0–1,550c 0–1,292c 0–1,550c
Heavy drinking episodes
per week .207b
M (SD) 1.6 (1.5) 1.78 (1.6) 1.41 (1.3)
Range 0–6 0–6 0–6
Alcohol-free days per week .957a
M (SD) 4.8 (1.8) 4.8 (1.7) 4.8 (1.8)
Range 0–7 1–7 0–7
Gender, n (%) .553d
Male 103 (83%) 52 (83%) 51 (84%)
Living status, n (%) .108d
Alone 33 (27) 19 (30%) 14 (23%)
Family/others 66 (53) 36 (57%) 30 (48%)
Unknown 25 (20) 8 (13%) 17 (27%)
Employment status, n (%) .899d
Full time 65 (53%) 32 (51%) 33 (54%)
Part time 4 (3%) 2 (3%) 1 (1%)
Student 3 (2%) 2 (3%) 2 (3%)
Unemployed 24 (19%) 12 (19%) 12 (20%)
Retired 22 (18%) 13 (21%) 9 (15%)
Not recorded 6 (5%) 2 (3%) 4 (7%)
Ward, n (%) .199d
Medical 75 (60%) 42 (67%) 33 (54%)
Orthopedic 49 (40%) 21 (33%) 28 (46%)
aIndependent t sample; bMann–Whitney U; csome participants did not drink in the week
before admission but still scored FAST positive (i.e., ≥3); those who identiﬁed that this was
atypical of their usual drinking pattern were included in the study (n = 16); dchi-square.
*p < .05.
TABLE 2. Summary of outcomes at 6-month follow-up comparison between control and intervention group (n
= 124)
Total sample Intervention Control
Outcome Variable (n = 124) group (n = 63) group (n = 61) p
Changes from baseline, M (SD) -50 (223) -97 (228) -12 (212) .03a
grams of alcohol per week Range -1,080–392 -643–905
Absolute weekly alcohol M (SD) 194 (226) 169 (184) 219 (263) .33a
Consumption, grams per week Range 0–1,549 0–864 0–1,549
Changes in heavy drinking M (SD) -0.33 (1.72) -0.65 (1.75) 0 (1.64) .043a
episodes, no. of days Range -6–6 -6–6 -5–6
Notes: No. = number. aMann–Whitney U.
A heavy drinking episode equates to 64 g of alcohol or
more for men or 48 g of alcohol or more for women on
one occasion (Institute of Alcohol Studies, 2013). Those
participants in the control group had no change in the mean
number of heavy drinking episodes per week, whereas those
in the intervention group showed a decrease of 0.65 days (or
just over half a day), representing a mean difference of -0.65
episodes (U = 1,537, p = .043) (Table 2).
Discussion
Following screening with the FAST, ABI delivered in ad-
dition to usual care within a general hospital setting to harm-
ful and hazardous drinkers was signiﬁcantly more effective
in reducing alcohol consumption (mean difference of 85 g
per week) than just screening and routine hospital care at 6
months (primary outcome). However, although there was a
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trend toward a greater reduction in the ABI group, there was
no signiﬁcant difference between the groups for absolute
alcohol consumption. In addition to these clinically impor-
tant gains, participants in the ABI group were also more
likely to report a reduction in the number of heavy drinking
episodes at 6-month follow-up (secondary outcome). If this
small weekly change was consistent, then over a 6-month
period this would equate to approximately 16 heavy drinking
episodes per person in the ABI group.
The variation in results between primary and second-
ary outcomes may be linked to the method of analysis.
The primary outcome—changes from baseline in grams
of alcohol per week—is calculated using baseline grams
of alcohol per week minus grams of alcohol per week at
6-month follow-up. This type of analysis is less vulnerable
to variability in participants’ drinking and, therefore, can
be more efﬁcient and powerful than simply comparing ﬁnal
values. However, the statistical signiﬁcance of the treat-
ment effect by the two methods will depend on the degree
of correlation between the results. If correlation is high, as
in this trial, using only the follow-up score, mean alcohol
consumption in grams per week will lose information and
the change score is more likely to be signiﬁcant; however,
if correlation is low, use of the change score will add varia-
tion and the follow-up score is more likely to be signiﬁcant
(Vickers & Altman, 2001). Using both outcomes in one
study has advantages in terms of triangulation but only if
the different measures point to results in the same direc-
tion. In this study, despite the differences in statistical
signiﬁcance, both outcomes point to the intervention group
consuming less alcohol at follow-up.
These results concur with those presented in a system-
atic review of ABI in a general hospital setting, conﬁrming
the effectiveness of ABI in reducing alcohol consump-
tion (McQueen et al., 2011). The systematic review of 14
studies indicates that patients receiving brief interventions
have a greater reduction in alcohol consumption compared
with those in control groups at 6- and 9-month follow-ups.
However, the small number of studies, relatively small
sample sizes, and heterogeneity between the studies re-
sulted in large conﬁdence intervals and less certainty as to
the true effects of ABI. This systematic review identiﬁed
the need for more studies within general hospital settings
(McQueen et al., 2011). Synergies between the ﬁndings are
reassuring, and future updates of the systematic review—
including newly published studies such as this one—will
add to the evidence base. Another systematic review ex-
amining the effectiveness of ABI in primary care indicated
that based on 22 studies, brief intervention resulted in sig-
niﬁcant reductions in weekly alcohol consumption for men
(Kaner at al., 2007).
The present study has several strengths. Of 3,761 admis-
sions during the 13-month recruitment period, 2,398 patients
were assessed for eligibility by screening with FAST, and
330 patients were eligible for recruitment. The randomiza-
tion process—administered by an independent therapist
using sequentially numbered, opaque, sealed envelopes—
ensured that participants had an equal chance of being al-
located to either the intervention or control group. The use
of assessors blind to group allocation further minimized the
risk of bias. A sample size calculation was used to determine
recruitment targets based on an estimated 30% attrition rate.
The attrition rate was correct because 70% of the partici-
pants were followed up 6 months later. This compares with
retention rates of between 68% and 100% in the 14 studies
included in the systematic review of ABI in general hospital
settings (McQueen et al., 2011). A further strength of this
study is that an intention-to-treat analysis was used.
The present study has limitations. The sample size
achieved for the trial of 87 completers was smaller than the
required sample size calculation of 294 (including a 30%
attrition rate); thus, power was not achieved. The potential
reasons for not achieving the target recruitment may have
been due to several factors. The sample was speciﬁcally
selected to include nondependent drinkers; therefore, the
results may not apply to dependent drinkers. We were not
able to screen all admissions, and recruitment took place
only 5 days a week, with no cover for annual leave. This was
compounded by the rapid nature of admission and discharge
for some patients.
Issues with consent, however, may clearly have a bear-
ing on overall ﬁndings. Of those patients who were eligible,
there was only endpoint data for 87 of 330 patients, only
26% of those who were actually eligible for the interven-
tion. Those participants who did not consent cited reasons
such as the fear of being stigmatized, concern their welfare
beneﬁts may be affected, or that the individual may not have
perceived his or her alcohol consumption to be problematic.
Offering participants incentives could potentially have im-
proved recruitment; however, there is considerable sensitivity
and some controversy over the use of incentives in research,
with much debate about whether such practice is ethical
(Grant & Sugarman, 2004).
The only difference between the groups at baseline was
that the mean FAST score was higher in the intervention
group (M = 6, range: 3–12), compared with the control
group (M = 5, range: 3–12). However, participants still were
in the harmful/hazardous range.
Telephone interviews were used for convenience at
6-month follow-up to collect data, and it is acknowledged
that the loss of nonverbal body language may be a limitation
in this study. The absence of visual cues via telephone could
result in the loss of contextual and nonverbal data, compro-
mising rapport, probing, and interpretation of responses. Yet,
it has been suggested that telephone interviews may allow
respondents to feel relaxed and able to disclose sensitive
information, and evidence is lacking that they produce lower
quality data (Novick, 2008).
844 JOURNAL OF STUDIES ONALCOHOLAND DRUGS / NOVEMBER 2015
Conclusions
Results from this study suggest that there are important
clinical beneﬁts to delivering ABI to hazardous/harmful
drinkers in general hospitals, with a signiﬁcantly greater
reduction in alcohol consumption among those in the in-
tervention group at 6-month follow-up. In addition, ABI is
more effective at achieving a reduction in reported episodes
of heavy drinking than screening and routine hospital care.
These results suggest that there are beneﬁts to increasing the
provision of this type of intervention with this population in
general hospitals. If implemented in most general hospitals,
this could result in a clinically important reduction in haz-
ardous or harmful levels of alcohol consumption. However,
it is unclear if these beneﬁts are sustained in the longer term
(i.e., beyond the 6-month follow-up period). Potentially,
there is the risk that alcohol consumption may rebound to
baseline, and further research with additional follow-up
and/or the provision of booster sessions could be worthy of
investigation.
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